Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests H Mejía-Rentería, N van der Hoeven, TP van de Hoef, J Heemelaar, ... The international journal of cardiovascular imaging 33, 1041-1059, 2017 | 57 | 2017 |
Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial TG Neilan, T Quinaglia, T Onoue, SS Mahmood, ZD Drobni, HK Gilman, ... Jama 330 (6), 528-536, 2023 | 49 | 2023 |
Acute-onset coma after iso-osmolar iodinated contrast injection: a case report of contrast-induced encephalopathy after elective coronary angiography JC Heemelaar, NW van der Hoeven, FF Muller, Y Appelman European Heart Journal-Case Reports 2 (4), yty132, 2018 | 10 | 2018 |
Impact of age at diagnosis on cardiotoxicity in high-grade osteosarcoma and Ewing sarcoma patients JC Heemelaar, FM Speetjens, AAM Al Jaff, RE Evenhuis, EAS Polomski, ... Cardio Oncology 5 (1), 117-127, 2023 | 5 | 2023 |
Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors JC Heemelaar, ADG Krol, M Louwerens, SLMA Beeres, ER Holman, ... IJC Heart & Vasculature 35, 100830, 2021 | 4 | 2021 |
Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study Q Chen, N van Rein, T van der Hulle, JC Heemelaar, SA Trines, ... European Heart Journal, ehae222, 2024 | 2 | 2024 |
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma JC Heemelaar, J Janson, J Braun, FM Speetjens, MAJ van de Sande, ... Cardio-Oncology 8 (1), 18, 2022 | 2 | 2022 |
Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients EAS Polomski, HW Kapiteijn, JC Heemelaar, T Kalisvaart, ... European Heart Journal 44 (Supplement_2), ehad655. 2692, 2023 | 1 | 2023 |
Treatment of immune checkpoint inhibitor-associated myocarditis JC Heemelaar, ML Antoni, TG Neilan Journal of Cardiovascular Pharmacology, 10.1097, 2022 | 1 | 2022 |
Clinical Heart Failure Events After Doxorubicin Treatment in High Grade Osteosarcoma Patients JC Heemelaar, ES Polomski, AA al Jaff, RE Evenhuis, MA van de Sande, ... Circulation 144 (Suppl_1), A11127-A11127, 2021 | 1 | 2021 |
Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site JC Heemelaar, T Berkhout, A Heestermans, JC Zant, AMJ de Vos, ... Journal of Interventional Cardiology 2021 (1), 4091289, 2021 | 1 | 2021 |
Detection of immune-related adverse events among hospitalized patients using large language models. VH Sun, JC Heemelaar, I Hadzic, VK Raghu, CY Wu, L Zubiri, ... Journal of Clinical Oncology 42 (16_suppl), 2638-2638, 2024 | | 2024 |
PATIENTS WITH A HISTORY OF CANCER HAVE AN INCREASED PREVALENCE OF CORONARY ATHEROSCLEROSIS COMPARED TO MATCHED PATIENTS WITHOUT CANCER EVALUATED ON CORONARY CT ANGIOGRAPHY EAS Polomski, JC Heemelaar, M De Ronde, JW Jukema, P Van Dijkman, ... Journal of the American College of Cardiology 83 (13_Supplement), 2346-2346, 2024 | | 2024 |
ARTERIAL INFLAMMATION ON [18F]FDG PET/CT IN ADVANCED MELANOMA PATIENTS TREATED WITH AND WITHOUT IMMUNE CHECKPOINT INHIBITOR … EAS Polomski, E Kapiteijn, JC Heemelaar, A Van De Burgt, P Dibbets, ... Journal of the American College of Cardiology 83 (13_Supplement), 2379-2379, 2024 | | 2024 |
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP R Nemec, M Scherrer-Crosbie, JS Abramson, R Redd, HK Gilman, T Ho, ... Leukemia & Lymphoma, 1-6, 2024 | | 2024 |
Age-related structural remodelling of the coronary microcirculation DC Faria, M Lombardi, NW van der Hoeven, A Travieso, JC Heemelaar, ... medRxiv, 2024.02. 27.24303474, 2024 | | 2024 |
Relation between coronary artery calcium score and cardiovascular events in Hodgkin lymphoma survivors: a cross-sectional matched cohort study EAS Polomski, JC Heemelaar, MA de Graaf, ADG Krol, M Louwerens, ... Cancers 15 (24), 5831, 2023 | | 2023 |
Effect of Sodium Glucose Cotransporter 2 Inhibitors on Major Adverse Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors PC Huang, TG Neilan, J Heemelaar, KSK Ma Circulation 148 (Suppl_1), A16478-A16478, 2023 | | 2023 |
Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis JC Heemelaar, T Quinaglia, ZD Drobni, J Ho, HK Gilman, DA Zlotoff, ... European Heart Journal 44 (Supplement_2), ehad655. 2711, 2023 | | 2023 |
Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study JC Heemelaar, S Heemelaar, SN Hertel, JW Jukema, M Sueters, ... BMC cancer 23 (1), 115, 2023 | | 2023 |